OpenNeedle Ask your own

Question explored with the scientific record

At 52 should I get the Covid vaccine

Sep 6, 2026 · 6 sources used · OpenNeedle synthesis
The short version: for a 52-year-old in 2026, the evidence for net benefit from another COVID-19 shot is thin and contradictory, and the burden of proof has not been met.

The evidence you need to weigh is a mess of conflicting signals. Several large observational studies claim vaccination cuts all-cause mortality by 50-60% [6, 7], but those same studies admit the unvaccinated comparison group is far sicker and older—the "healthy vaccinee effect" they try to correct for is massive and never fully removed [7]. Meanwhile, other population-level studies find the opposite: higher vaccination uptake in a country or county predicts higher all-cause excess mortality in the following year [3, 8]. The UK's own ONS data shows that vaccinated individuals' risk of death relative to unvaccinated started low but crossed over to significantly higher by late 2021 and stayed there for most age groups [5]. A Norwegian study funded by the Norwegian Institute of Public Health (not pharma) found lower mortality in the vaccinated [6], but a US county-level study of over 3,000 counties found the reverse [3]. These are not minor disagreements. They are the literature eating itself.

What is missing is the study that would settle this: a randomized trial comparing vaccinated to unvaccinated adults on all-cause mortality over several years. That trial was never run. Every study here is observational, and observational studies comparing the vaccinated to the unvaccinated are structurally confounded by who chooses to get vaccinated and who does not. The manufacturer-funded trials that got these vaccines approved measured antibody titers and symptomatic COVID-19 over a few months [21], not death from any cause over years. For a 52-year-old with no high-risk condition, the absolute risk of dying from COVID-19 is now very low—the virus has become endemic and far less lethal. The absolute risk reduction from another shot is therefore also very low, while the signal of possible harm (elevated all-cause mortality in some of the largest datasets [3, 5, 8]) is not zero.

Study typeWhat it foundKey limitation
Norwegian cohort (2026) [6]58% lower all-cause mortality in vaccinatedHealthy vaccinee bias; unvaccinated were older, sicker
UK ONS data (2025) [5]Vaccinated mortality crossed over to higher than unvaccinated by late 2021Observational; residual confounding possible
US county-level (2026) [3]Higher vaccine uptake predicted higher excess mortality in 2022-2023Ecological; cannot prove causation
European country-level (2023) [8]Higher 2021 uptake predicted higher 2022 monthly mortalityEcological; authors caution against causal interpretation

My call: for a 52-year-old without major risk factors, the evidence does not clearly show that another COVID-19 shot will extend your life, and some of the largest population studies suggest it may not. The burden of proof is on the injection, and it has not been met. Confidence: moderate.

Keep digging

Sources used 6

  1. Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people F1000Research (2026) primary study Strong

    A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.

    DOI: 10.12688/f1000research.177279.1
  2. All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data F1000Research (2025) primary study Strong

    The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…

    DOI: 10.12688/f1000research.154058.2
  3. COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study BMJ Public Health (2026) primary study Strong

    In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…

    DOI: 10.1136/bmjph-2024-001859
  4. Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study Vaccines (2022) primary study Strong

    In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…

    DOI: 10.3390/vaccines10071009
  5. Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality? Asian Pacific Journal of Health Sciences (2023) primary study Strong

    Analyses of 31 European countries found that higher 2021 COVID-19 vaccination uptake was associated with greater increases in monthly all-cause excess mortality during the first nine months of 2022, although the authors caution against causal interpretation and ecological fallac…

    DOI: 10.21276/apjhs.2023.10.1.6
  6. VACCIN COMIRNATY CONTRE LA COVID-19 : UNE AIDE A LA DECISION EXERCER (2021) other Strong

    This advisory from the scientific council of CNGE summarizes the Pfizer-BioNTech Comirnaty COVID-19 vaccine trial, reporting 95% relative risk reduction for symptomatic COVID-19, describes common side effects, and notes missing data on older adults, hospitalizations, mortality, …

    DOI: 10.56746/exercer.2021.169.23

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question